LYC HEALTHCARE (CAYMAN) LTD

Services-Offices & Clinics of Doctors of Medicine

ipo amended Nasdaq F-1

Filing Timeline

SEC EDGAR

F-1 filed

Initial foreign registration statement

Initial public filing for a foreign issuer submitted to start the SEC review process.

Follows DRS/A in the pre-IPO sequence.

Price $5.00 · Range $4.00 to $6.00 · 3,000,000 shares · Gross proceeds $15,000,000

Class A · Exchange Nasdaq · Over-allotment 450,000 · Underwriters will receive warrants exercisable at 120% of public offering price for 7% of shares sold · Use of proceeds for general corporate purposes including working capital · Flags cayman_holding_company, dual_class · Underwriters AC Sunshine Securities LLC

LYC Healthcare (Cayman) Ltd. is conducting an initial public offering (IPO) of 3,000,000 Class A ordinary shares at an estimated price range of $4.00 to $6.00 per share. The company, a Cayman Islands exempted holding company, operates through Singapore subsidiaries and is seeking Nasdaq listing under an unspecified symbol. The IPO includes underwriter over-allotment options and warrants, with proceeds intended for general corporate purposes. The company is classified as an emerging growth company and a foreign private issuer, subject to reduced reporting requirements.

2025-12-08 · 0001493152-25-026522

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS filing.

LYC Healthcare (Cayman) Ltd. is conducting an initial public offering (IPO) of Class A ordinary shares, with an anticipated price range of US$[●] to US$[●] per share. The company, a Cayman Islands holding company, operates through Singapore subsidiaries and is seeking Nasdaq listing under symbol [●], though approval is pending. The offering includes 70,000,000 Class A shares (1 vote each) and 30,000,000 Class B shares (10 votes each, convertible to Class A). The IPO is led by AC Sunshine Securities LLC as underwriter, with a 7% gross discount. The company is classified as an emerging growth company and a foreign private issuer, subject to reduced reporting requirements. Post-IPO, LYC Medicare Sdn Bhd will control over 50% of voting power, creating a controlled company structure.

2025-05-29 · 0001641172-25-012781

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

First tracked pre-IPO filing for this issuer.

LYC Healthcare (Cayman) Ltd is conducting its initial public offering (IPO) of Class A ordinary shares, with an anticipated price range of US$[●] to US$[●] per share. The company, a Cayman Islands exempted holding company, operates through Singapore subsidiaries and plans to list on Nasdaq under the symbol [●], though approval is pending. The offering includes 70,000,000 Class A shares and 30,000,000 Class B shares, with Class B shares carrying ten votes per share and conversion rights. Post-offering, LYC Medicare Sdn Bhd will control over 50% of voting power, making the company a controlled entity. The filing highlights risks including lack of public market liquidity, uncertainty around Nasdaq approval, and potential dilution from Class B share issuances. The company qualifies as an emerging growth company and foreign private issuer, with reduced reporting requirements.

2024-12-31 · 0001493152-24-052587